Systematic reviews

Effects of cycling exercise in people with chronic kidney disease: plan for a detailed review and combined analysis

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Abstract

Approximately 10% of the adult population is affected by chronic kidney disease.

  • Chronic kidney disease is associated with long-term complications despite conventional management.
  • Cycling exercise may enhance cardiopulmonary function and renal outcomes in patients with advanced chronic kidney disease.
  • Conflicting evidence exists regarding the efficacy of cycling exercise compared to usual care.
  • A systematic review will analyze randomized controlled trials comparing cycling exercise and usual care.
  • Risk of bias in the included studies will be evaluated to ensure the reliability of findings.

Simplified

Full Text

We can’t show the full text here under this license.
View Full Text ↗

Funding

Competing interests

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing financial interests or personal relationships that may have influenced the work reported in this study.
PubMed

Related papers

Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 30 papers
systematic review
Oct '25
Effectiveness of dance movement therapy for managing weight in overweight or obese adults
top 5% journal
journal article
Jan '26
Effectiveness and safety of a minimally invasive stomach tightening procedure for patients with fatty liver disease linked to metabolism problems
top 5% journal
journal article
Mar '25
How nutrient supplements may help malnutrition and muscle loss in people with COPD
top 5% journal
cited by 2 papers
research support, non-u.s. gov't
Oct '20
The Future Directions of Cochrane Neonatal Research
top 30% journal
cited by 19 papers
research support, non-u.s. gov't
Dec '25
Effects of glucagon-like peptide-1 receptor agonists on patients with fatty liver disease linked to metabolism: plan for a detailed review and analysis
top 5% journal
journal article
Nov '25
Peer-led or peer-supported physical activity and health in older adults living in the community
top 20% journal
cited by 1 paper
journal article

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
2 days ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
1 week ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
2 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
3 weeks ago7 studies
issue #44
Tirzepatide cut all-cause mortality by more than half compared to semaglutide in a 47,000-patient study
4 weeks ago7 studies
issue #43
Semaglutide linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients
5 weeks ago7 studies
issue #42
Tirzepatide users lost 14.7% of body weight vs. 10.8% with semaglutide — but Black and Hispanic patients were overrepresented in the lowest-response group
6 weeks ago8 studies
issue #41
New obesity drug survodutide cut weight by 13% vs 5.4% for placebo in 725 patients
7 weeks ago7 studies
issue #40
GLP-1 users had 3x higher risk of aspiration pneumonia after stroke surgery
8 weeks ago7 studies
issue #39
Semaglutide linked to reduced cigarette craving in 24 smokers
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief